Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005079
Filing Date
2025-07-17
Accepted
2025-07-17 16:18:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4009
  Complete submission text file 0001950047-25-005079.txt   5479
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Subject) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39083 | Film No.: 251130849
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Eisner Mark (Reporting) CIK: 0001834161 (see all company filings)

Type: 144